Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Melchers

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Professional Nurse (London, England)|May 25, 2002
Safety for transfusion patientsR Melchers
Tissue Antigens|April 21, 2007
HLA-DQB1 sequencing-based typing updatedA van Dijk, R Melchers, M Tilanus, et al.
Tissue Antigens|April 21, 2007
HLA-DRB sequencing-based typing: an improved protocol which shows complete DRB exon 2 sequences and includes exon 3 of HLA-DRB4/5A van Dijk, R Melchers, Y Hilkes, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 23, 2003
Chemotherapy, erythropoietin and bloodless surgery in a Jehovah's WitnessJ E Brown, M Q Hatton, R Melchers, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Professional Nurse (London, England)|May 25, 2002
Safety for transfusion patientsR Melchers
Tissue Antigens|April 21, 2007
HLA-DQB1 sequencing-based typing updatedA van Dijk, R Melchers, M Tilanus, et al.
Tissue Antigens|April 21, 2007
HLA-DRB sequencing-based typing: an improved protocol which shows complete DRB exon 2 sequences and includes exon 3 of HLA-DRB4/5A van Dijk, R Melchers, Y Hilkes, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 23, 2003
Chemotherapy, erythropoietin and bloodless surgery in a Jehovah's WitnessJ E Brown, M Q Hatton, R Melchers, et al.
Pageof 1